The U.S. Food and Drug Administration has approved Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine ...
The U.S. Food and Drug Administration has approved Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema.
More than 240 school districts, along with 70 in-state producers took part in the program during its first year.
Patients who use smartphone apps to manage their diabetes could face serious health problems if they miss notifications ...